Skip to main content

A Study on the Serum Concentration of Lentinan Administered via Various Routes in Tumor Bearing Mice and in Human Breast Cancer Patients: In Relation to Antitumor Effect

  • Conference paper
Immunotherapeutic Prospects of Infectious Diseases
  • 58 Accesses

Abstract

We have reported on the efficacy of antitumor polysaccaride lentinan against breast cancer through experimental studies and clinical trials, and also on the mechanism of antitumor action of lentinan. Attempts in the present study have been made to elucidate the relationship between the in vivo pharmacokinetics of lentinan and its antitumor effect. We investigated pharmacokinetics of lentinan administered via various routes into sarcoma 180 bearing mice and mammary cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Kosaka, A., Hattori, Y., Imaizumi, A. et al.: Synergistic effect of lentinan and surgical endocrine therapy on the growth of DMBA-induced mammary tumors of rats and of recurrent breast cancer. In Rational of Biological Responce Modifiers in Cancer Treatment. ed. by E. Tsubura, I. Urushizaki and T. Aoki, Excerpta Medica, pp. 138–150, 1985.

    Google Scholar 

  2. Kosaka, A., Imaizumi, A., Yamashita, A. et al.: Nature of the antitumor of lentinan-endocrine therapy on the mammary in Host Defense Mechanisms Against Cancer. ed. by I. Urushiaki, T. Aoki and E. Tsubura, Excerpta Medica, pp. 208–220, 1986.

    Google Scholar 

  3. Kosaka, A., Yamashita, A.: Lentinan. Jpn. J. Breast Cancer 2 (1): 21–36, 1987.

    Google Scholar 

  4. Iwanaga, S., Morita, T., Miyata, T. et al: The limulus coagulation system sensitive to bacterial endotoxin: Chemical, Biological and Clinical Aspects, ed. by Homma, J. Y. et al, pp. 365–382, Verlag Chemie, Weinheim, 1984.

    Google Scholar 

  5. Yoshiaki Yajima, Jo Satoh, Takako Kikuchi.: Change of blood lentinan level in Patients with advanced Cancers. Jpn J Chemother 16 (8): part-1, pp. 2633–2638, August, 1989.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kosaka, A., Kuzuoka, M., Yamashita, A., Takino, Y., Tanizawa, H., Bandou, K. (1990). A Study on the Serum Concentration of Lentinan Administered via Various Routes in Tumor Bearing Mice and in Human Breast Cancer Patients: In Relation to Antitumor Effect. In: Masihi, K.N., Lange, W. (eds) Immunotherapeutic Prospects of Infectious Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76120-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76120-1_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76122-5

  • Online ISBN: 978-3-642-76120-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics